Delivery Order SPE2DB22D3301-SPE2DB25FY4TX

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,539.46, is for the supply of ceftriaxone 1 gram intravenous (IV) bags. The contract has a firm fixed price and an ultimate completion date of January 8, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for $5,099.64 to supply 4,565,322,689 units of Ceftriaxone 2 GM-D5W bags. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,458.03, is for the delivery of 4,564,139,523 units of Ceftriaxone 1 GM-D5W bags. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,927,129 units of the antibiotic Ceftriaxone 1 GM-D5W Bags, with a ceiling value of $1,432.71. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,927.13, is for the provision of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product used in medical treatment. The contract has a period of performance through January 29, 2025 and utilizes a Firm Fixed Price pricing structure. This Delivery Order is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,166.96, is for the delivery of ceftriaxone 2 GM-D5W bags, a type of antibiotic medication. The contract has a firm fixed price pricing type and runs through March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is a delivery order (SPE2DB23FRYU0) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,817.70 firm-fixed-price contract is for the delivery of 4,562,299,392 units of Ceftriaxone 1 GM-D5W bags, a critical injectable medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4,564,898,016 units of Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has a ceiling value of $4,658.17 and is a firm-fixed price delivery order, with a completion date of June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, with a ceiling value of $2,629.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,228,680 units of ceftriaxone 2 GM-D5W bags, a pharmaceutical product used to treat various bacterial infections. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of May 14, 2025. It is not...
This federal contract award, valued at $1,773.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 2 GM-D5W bags, a type of antibiotic medication, with an ultimate completion date of April 16, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY4TX
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,236,483 units of ceftriaxone 2 gram IV bags, with a ceiling value of $10,609.56 and a period of performance through May 14, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order contract is not set aside and was awarded through open competition. The contract supports the federal government's medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/12/25, 12:13 PM